Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coudert

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2012
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypesO Humbert, A Berriolo-Riedinger, J M Riedinger, et al.
Thorax|August 1, 1992
Nilutamide pneumonitis: a report on eight patientsP Pfitzenmeyer, P Foucher, F Piard, et al.
European Journal of Cancer Care|October 28, 2015
HER2-positivity rates in breast cancer: no variation over time when clinicopathological features and testing are stableF Beltjens, A Bertaut, S Pigeonnat, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancerC Dittrich, B Coudert, L Paz-Ares, et al.
British Journal of Cancer|September 17, 2009
Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinomaF Végran, R Boidot, B Coudert, et al.
European Journal of Clinical Pharmacology|July 10, 2021
Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancerA Petitcollin, N Azzopardi, J Y Pierga, et al.
British Heart Journal|January 1, 1995
Impairment of diastolic function during short-term anthracycline chemotherapyY Cottin, C Touzery, B Coudert, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot studyN Isambert, M Correia, J P Cercueil, et al.
Bulletin Du Cancer|October 1, 1996
[Feasability of the dose adjustment of continuous infusion administration over 120 hours of 5-fluorouracil associated with cisplatin]B Coudert, C De Gislain, J L Beltramo, et al.
European Journal of Cancer Care|May 8, 2013
Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based studyT S Dabakuyo, A Arnaud, P Maingon, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2012
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypesO Humbert, A Berriolo-Riedinger, J M Riedinger, et al.
Thorax|August 1, 1992
Nilutamide pneumonitis: a report on eight patientsP Pfitzenmeyer, P Foucher, F Piard, et al.
European Journal of Cancer Care|October 28, 2015
HER2-positivity rates in breast cancer: no variation over time when clinicopathological features and testing are stableF Beltjens, A Bertaut, S Pigeonnat, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancerC Dittrich, B Coudert, L Paz-Ares, et al.
British Journal of Cancer|September 17, 2009
Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinomaF Végran, R Boidot, B Coudert, et al.
European Journal of Clinical Pharmacology|July 10, 2021
Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancerA Petitcollin, N Azzopardi, J Y Pierga, et al.
British Heart Journal|January 1, 1995
Impairment of diastolic function during short-term anthracycline chemotherapyY Cottin, C Touzery, B Coudert, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot studyN Isambert, M Correia, J P Cercueil, et al.
Bulletin Du Cancer|October 1, 1996
[Feasability of the dose adjustment of continuous infusion administration over 120 hours of 5-fluorouracil associated with cisplatin]B Coudert, C De Gislain, J L Beltramo, et al.
European Journal of Cancer Care|May 8, 2013
Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based studyT S Dabakuyo, A Arnaud, P Maingon, et al.
Pageof 10